Categoria: Articoli in lingua originale

Pioglitazone Decreases Type 2 Diabetes Risk in Stroke Patients with Insulin Resistance #2016ADA

Pioglitazone greatly decreases the risk of developing type 2 diabetes, especially for those who already have prediabetes and/or who have had strokes, according to a study presented at the American Diabetes Association’s 76th Scientific Sessions® at the Ernest N. Morial Convention Center in New Orleans.   The Insulin Resistance Intervention after Stroke trial (IRIS)[1]

Continua a leggere

Eye study underscores the long-lasting benefits of controlling diabetes

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy. Investigators

Continua a leggere

Abbott Announces Positive Results From Groundbreaking Study Of FreeStyle® Libre System For People With Type 1 Diabetes

New Orleans, LA /PRNewswire/ – Abbott (NYSE: ABT) today announced the results of the IMPACT clinical trial, which demonstrated that the FreeStyle® Libre system met its primary endpoint of a reduction in time spent in hypoglycemia (low glucose levels, defined as <70 mg/dL1) for people with type 1 diabetes. People in

Continua a leggere

Home Use of a Dual Hormone, Bionic Pancreas Safely Reduces Blood Glucose Levels and Hypoglycemia in Adults While Continuing Normal Daily Activities #2016ADA

Use of a biohormonal, bionic pancreas in the home setting can safely and effectively lower mean blood glucose levels and hypoglycemia (low blood glucose), compared to the use of an insulin pump, in adults with type 1 diabetes performing normal daily activities, according to a study presented at the Association’s

Continua a leggere

First Type 1 Diabetes Patient in Europe is Free from Insulin Therapy after Undergoing Diabetes Research Institute’s BioHub Transplant Technique

Miami, FL – June 9, 2016 – A 41-year-old man who was diagnosed with type 1 diabetes at age 11 has become the first patient in Europe to discontinue insulin therapy after receiving a transplant of pancreatic islet cells using an innovative technique developed by the Diabetes Research Institute (DRI)

Continua a leggere

Artificial Pancreas Success in Type 1 Diabetes in Pregnancy

The first-ever study to examine use of a closed-loop insulin-delivery system — the so-called “artificial pancreas” — in an outpatient home setting in pregnant womenwith type 1 diabetes has shown some success, reducing hyperglycemia on the order of 25%. While there is increasing use of this “closed-loop” approach — which employs

Continua a leggere

Diabetes Research Institute Celebrates a Decade of Freedom From Insulin Injections for Third Islet Transplant Patient

Miami, FL (February 11, 2016) – Celebrating a significant 10-year milestone, Tallahassee resident Chris Schuh, 64, is grateful to be alive. Diagnosed with type 1 diabetes at age 30, Schuh received an islet cell transplant at the Diabetes Research Institute (DRI), and has been living free from insulin injections for

Continua a leggere

Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation

Abstract Aims To report contemporary regression rates from impaired glucose regulation to normal glucose tolerance, identify modifiable factors associated with early regression, and establish whether it affects subsequent diabetes risk in a population-based cohort. Methods Participants with impaired glucose regulation (impaired fasting glucose and/or impaired glucose tolerance on a 75-g

Continua a leggere
Skip to content